News To sign up to our newsletter, complete this form To end your subscription, unsubscribe from this list 2023 / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 ACCOMPLISH in New England Journal of MedicineDecember 05, 2008 The ACCOMPLISH study demonstrated that a combination of benazepril and amlodipine was superior to the combination of benazepril and hydrochlorotizide in reducing cardiovascular events in patients with hypertension who were at risk for such events. Read more60% of all clinical trials miss their deadlinesOctober 23, 2008 And more than 80% of the delays are due to poor patient recruitment. Read moreThank you for making it a successful housewarming!October 20, 2008 Thank you everyone for coming and celebrating our new office location with us in Lund, October 16th. We had fun networking with clients, friends and former colleagues! Read moreGothenburg office houses GCP theme daySeptember 15, 2008 In the beginning of September, one of four GCP theme days, organized by the Swedish Academy of Pharmaceutical Sciences, took place at A+ Science offices in Gothenburg. About 80 people attended seminars headed by several interesting speakers, among others Gunnar Danielsson from the MPA. Read more2 500 cardiologists attends accredited CMESeptember 10, 2008 Continuing medical education (CME) help professionals in the medical field maintain competence and learn about new and developing areas of their field. CME often takes place as live events headed by highly renowned researchers and opinion leaders. Read moreVita Nova Group acquires NMCT’s patient recruitmentJune 25, 2008 A+ Science AB, the subsidiary company of Vita Nova Ventures has today reached an agreement to acquire part of the business activities in the bankrupt estate of NMCT AB in Gothenburg. Read moreMeet us at Hypertension 2008June 10, 2008 The Hypertension 2008 expects 7 000 participants from the Life Science Industry. The meeting offers a program with the latest results in the field of hypertension and many exhibitors showing off their latest news. Read moreThe Stockholm offices have movedJune 02, 2008 On Monday June 2nd 2008 A+ Science’s two Stockholm offices merged into one at Solna Business Park. Read moreThe Allay trial at ACC08April 15, 2008 During the Annual American College of Cardiology 2008 Scientific Sessions, (ACC 08) held in Chicago in March, another successful study, the ALLAY Trial, was presented. A+ Science has been responsible for the ECG handling and coding of all ALLAY ECGs. Read morePreliminary results ACCOMPLISH trialApril 02, 2008 Preliminary results of the ACCOMPLISH Trial show that a combination therapy with ACE inhibitor plus calcium –channel blocker is more effective than a treatment with the ACE inhibitor plus diuretic. Read moreBreakfast meeting May 19, 2008March 27, 2008 in Swedish only. Read moreUpcoming news in cardiovascular and metabolic diseasesMarch 26, 2008 ALLAY is the largest study on regression of left ventricular hypertrophy with MRI technique and included over 400 patients in seven countries from all over the world. ACCOMPLISH is a comparison study of two fixed combination drugs (more below) and included over 11 000 patients in six countries. Read moreCity Site - a new Clinical Research unitFebruary 04, 2008 A+ Science Clinical Services AB launches a Clinical Pharmaceutical Research unit in the heart of Stockholm. The doors open up today in one of the tall buildings located at Hötorget on Sveavägen 17. The research unit, A+ Science City Site, will be conducting clinical trials within many different therapeutic fields. The unit is well equipped and accessible for patient recruitment within a very short time. A+ Science specializes in clinical trials and through this specialization it promises a faster accomplishment and top quality trials. The clients are pharmaceutical companies, medical device companies and individual researchers. Read moreClinical trial symposium held in MoroccoJanuary 17, 2008 A+ Science played an important part in a clinical trial symposium held at the Faculty of Medicine in Marrakech Morocco. The discussion centered on how Morocco could become a competitive player in the area of clinical trials. The collaboration between A+ Science and several key representatives from authorities, Ethics Committee, universities and interest groups managed to reveal issues needing attention as well as promising opportunities; knowledge that given time and collaboration could make Morocco an important contributor to clinical research. Read more